Reaction
Butterfly Rash reporting signals
As of the last recalculation, Butterfly Rash appears in 989 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is INDAPAMIDE (PRR 83.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Indapamide | 66 | 83.0 | 83.3 |
| Belimumab | 59 | 41.6 | 41.7 |
| Progesterone | 37 | 35.3 | 35.4 |
| Hydroxychloroquine | 106 | 33.3 | 33.4 |
| Ivacaftor | 12 | 32.2 | 32.2 |
| Tofacitinib Citrate | 18 | 29.4 | 29.5 |
| Voclosporin | 10 | 24.5 | 24.5 |
| Diphenhydramine | 61 | 21.6 | 21.6 |
| Leucovorin Calcium | 19 | 21.3 | 21.3 |
| Apixaban | 63 | 21.1 | 21.1 |
| Leflunomide | 85 | 18.6 | 18.6 |
| Amikacin | 13 | 16.2 | 16.3 |
| Olanzapine | 75 | 15.8 | 15.8 |
| Hydroxychloroquine Sulfate | 63 | 15.5 | 15.5 |
| Mycophenolic Acid | 23 | 15.5 | 15.5 |
| Sertraline | 77 | 14.9 | 14.9 |
| Estradiol Gel 0.1% | 29 | 13.9 | 13.9 |
| Estradiol Transdermal | 29 | 13.9 | 13.9 |
| Loratadine Oral | 31 | 13.7 | 13.7 |
| Loratadine Tablet | 28 | 11.3 | 11.3 |
| Pyrazinamide | 5 | 11.3 | 11.3 |
| Timolol | 5 | 8.7 | 8.8 |
| Canakinumab | 4 | 7.8 | 7.8 |
| Rimegepant Sulfate | 3 | 5.0 | 5.0 |